Prana Biotechnology is on the Cruelty Free Investing list for exploiting animals because the company does animal testing for some of their medical analysis and clinical research.
The company stated in the following report that they conduct pre-clinical trials of their drugs on animals.
“As we will describe in more detail below, PBT2 appears to restore transition metal homeostasis in AD and HD, leading to disaggregation of Aβ and improvement of cognitive function and memory in animal models of AD and earlystage clinical trials of patients with AD, and prevention of mHtt aggregation and brain atrophy while improving motor function in animal models of HD.” (Page 4) Read the full document
Prana Biotechnology Ltd. engages in the development of therapies to treat neurodegenerative disease. It includes research and development of treatments for Alzheimer’s and Huntington’s disease. [Source: MarketWatch]
Company Website: http://pranabio.com